Investments
49Portfolio Exits
5Funds
1About Allegro Investment Fund
Allegro Investment Fund is a privately held investment fund. They invest in companies ranging from startups to established businesses across a broad range of industries and geographies.They focus on the long term strategic development of their investments rather than focus on short term results and exit strategies
Allegro Investment Fund Headquarter Location
525 Middlefield Road Suite 220
Menlo Park, California, 94025,
United States
Latest Allegro Investment Fund News
Jan 28, 2021
Sight Sciences, Inc. , a Menlo Park, CA-based commercial stage ophthalmic medical device company, closed a $7m Series B financing round. The round was led by Hicks Equity Partners, with participation from Series A investors Scientific Health Development, Allegro Investment Fund, and various other institutional and angel investors. The company intends to use the funds to build out the management team, scale manufacturing, support product development, and initiate a series of clinical studies. Led by Paul Badawi, President and CEO, Sight Sciences is a medical device company dedicated to the development of technology-driven solutions that address the underlying physiology of ophthalmic disease. The company operates surgical and non-surgical device business lines. Its surgical product portfolio consists of the TRAB™360 and VISCO™360 surgical devices. Its non-surgical product portfolio consists of technologies in the advanced stages of development for evaporative dry eye. FinSMEs
Allegro Investment Fund Investments
49 Investments
Allegro Investment Fund has made 49 investments. Their latest investment was in Sight Sciences as part of their Series F on December 12, 2020.
Allegro Investment Fund Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/10/2020 | Series F | Sight Sciences | $23.25M | No | 1 | |
8/9/2019 | Series D | Sight Sciences | $31M | No | 5 | |
6/4/2018 | Series C - II | Sight Sciences | $9.73M | No | 1 | |
7/20/2017 | Series C | |||||
10/26/2016 | Series D |
Date | 12/10/2020 | 8/9/2019 | 6/4/2018 | 7/20/2017 | 10/26/2016 |
|---|---|---|---|---|---|
Round | Series F | Series D | Series C - II | Series C | Series D |
Company | Sight Sciences | Sight Sciences | Sight Sciences | ||
Amount | $23.25M | $31M | $9.73M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 1 | 5 | 1 |
Allegro Investment Fund Portfolio Exits
5 Portfolio Exits
Allegro Investment Fund has 5 portfolio exits. Their latest portfolio exit was Sight Sciences on July 16, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/16/2021 | IPO | 1 | |||
Date | 7/16/2021 | ||||
|---|---|---|---|---|---|
Exit | IPO | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 |
Allegro Investment Fund Fund History
1 Fund History
Allegro Investment Fund has 1 fund, including Allegro Investment Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
Allegro Investment Fund | 1 |
Closing Date | |
|---|---|
Fund | Allegro Investment Fund |
Fund Type | |
Status | |
Amount | |
Sources | 1 |
Allegro Investment Fund Team
4 Team Members
Allegro Investment Fund has 4 team members, including current President, Alex Van Den.
Name | Work History | Title | Status |
|---|---|---|---|
Alex Van Den | President | Current | |
Marie Encrantz | Chief Financial Officer | Current | |
Staffan Encrantz | Managing Partner | Current | |
Geert Everaert | Owner | Current |
Name | Alex Van Den | Marie Encrantz | Staffan Encrantz | Geert Everaert |
|---|---|---|---|---|
Work History | ||||
Title | President | Chief Financial Officer | Managing Partner | Owner |
Status | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.